Citation Impact
Citing Papers
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
Urine markers for detection and surveillance of bladder cancer
2013
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
2012
Effects of Comorbidities on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasms
2015
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines
2013
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Diagnostic biomarkers in non-muscle invasive bladder cancer
2018
Sarcopenia
2019 Standout
Epidemiology and Risk Factors of Urothelial Bladder Cancer
2012 Standout
Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers
2013
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
2011
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
2015
Molecular Markers for Bladder Cancer Screening, Early Diagnosis, and Surveillance: The WHO/ICUD Consensus
2014
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non–muscle-invasive bladder cancer with positive results on urine cytology
2014
Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review
2012
Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
2013
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
2017 Standout
Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer
2018
Bladder Cancer
2020 Standout
Urinary Biomarkers for Diagnosis of Bladder Cancer
2015
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Works of Thomas Martini being referenced
Fluorescence In Situ Hybridisation in the Diagnosis of Upper Urinary Tract Tumours
2010
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer
2012
Comparison of Complications in Three Incontinent Urinary Diversions
2008
Impact of the Use of Bowel for Urinary Diversion on Perioperative Complications and 90-Day Mortality in Patients Aged 75 Years or Older
2015
Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study
2011
A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study
2012
Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder
2012
Comorbidity and Performance Indices as Predictors of Cancer-Independent Mortality But Not of Cancer-Specific Mortality After Radical Cystectomy for Urothelial Carcinoma of the Bladder
2012
Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer
2018
Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
2013